Head-to-head · free
CareDx, Inc. vs Joint Stock Company Kaspi.kz
CDNA vs KSPI — return on capital, cash generation, margins and balance sheet side by side.
CDNA
1 / 4
measures where CDNA leads
KSPI
3 / 4
measures where KSPI leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | CDNA · FY2025 | KSPI |
|---|---|---|
| Revenue | $379.8M | — |
| Net income | (21.4M) | — |
| Revenue growth (yearly, multi-year) | 6.4% | — |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | — | 42.8% |
| Return on equity | -6.3% | 53.5% |
| Gross margin | 67.6% | 47.4% |
| Operating margin | -6.6% | 32.6% |
| Net debt / EBITDA | 6.31x | -0.35x |
Figures are as reported by each company; latest fiscal year shown.
Where CareDx, Inc.'s cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free